Efficacy and safety of anlotinib in overall and disease-specific advanced gynecological cancer: A real-world study

Xinyi Hong,Shanhu Qiu,Xia Wu,Sizhen Chen,Xiaoxiang Chen,Bei Zhang,Aiqin He,Ying Zhou,Yun Xu,Jianqing Wang,Yingchun Gao,Xizhong Xu,Li Sun,Yang Zhang,Libing Xiang,Jundong Zhou,Qun Guan,Bingwei Chen,Yang Shen

Drug design, development and therapy（2023）

引用 0|浏览13

暂无评分

摘要

In conclusion, Anlotinib holds promise in treating patients with advanced gynecological cancer including its disease-specific types, with reasonable efficacy and tolerable safety.

查看译文

关键词

molecular-targeting therapy, angiogenesis inhibitors, real-world study

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要